Related Experiment Videos
Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence
S S Deo1, S M Merchant, A C Kapadia
1Immunology Department, Aditya Pediatric Research Laboratory, Bai Jerbai Wadia Hospital for Children, Parel, Bombay.
Indian Journal of Pediatrics
|July 1, 1994
Summary
Polymorphonuclear cell function in beta-thalassemia major patients is active, even with autologous serum. This enhanced activity is linked to transfusions, not iron overload, suggesting a need for further investigation into immune responses.
Area of Science:
- Immunology
- Hematology
Background:
- Beta-thalassemia major patients often experience immune dysregulation.
- Polymorphonuclear cell (PMN) function and opsonic activity are crucial for innate immunity.
Purpose of the Study:
- To evaluate PMN metabolic function and serum opsonic activity in beta-thalassemia major patients.
- To investigate the role of chemiluminescence assay (CL) in assessing phagocytic function.
Main Methods:
- Chemiluminescence assay (CL) was used to measure PMN metabolic function and opsonic activity.
- Patients were categorized into normal adults, thalassemia major < 5 years, and thalassemia major > 5 years groups.
- PMN function was assessed using autologous and normal sera.
Main Results:
- A statistically significant increase in PMN peak count was observed in older thalassemia major patients (Group III) compared to normal adults (Group I).
- No significant decrease in PMN function was noted in thalassemia patients when using their own or normal serum.
- Thalassemia patients' PMNs showed activity in the presence of both autologous and normal serum.
Conclusions:
- Polymorphonuclear cells in beta-thalassemia major patients exhibit normal to enhanced function.
- The increased PMN activity is potentially due to antigenic stimulation from multiple transfusions, not iron overload.
- The chemiluminescence assay is a valuable tool for evaluating phagocytic function in these patients.